Sidoti Events, LLC's Virtual September Small-Cap Conference
STAAR Surgical (NASDAQ:STAA) Has Some Way To Go To Become A Multi-Bagger
Baillie Gifford Reduces Stake in Staar Surgical Co
Staar Surgical Is Maintained at Buy by Stifel
Staar Surgical Price Target Cut to $44.00/Share From $50.00 by Stifel
Analyst Expectations For Staar Surgical's Future
Stifel Maintains Buy on Staar Surgical, Lowers Price Target to $44
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $44
Stifel analyst Thomas Stephan maintains $Staar Surgical(STAA.US)$ with a buy rating, and adjusts the target price from $50 to $44.According to TipRanks data, the analyst has a success rate of 66.7%
Express News | STAAR Surgical Co : Stifel Cuts Target Price to $44 From $50
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $41
CCORF analyst John Young CFA maintains $Staar Surgical(STAA.US)$ with a hold rating, and maintains the target price at $41.According to TipRanks data, the analyst has a success rate of 71.4% and a
Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
STAAR Surgical To Present At Canaccord Genuity Growth Conference; Webcast At 8:30 AM ET
Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention
The Three-year Loss for STAAR Surgical (NASDAQ:STAA) Shareholders Likely Driven by Its Shrinking Earnings
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Staar Surgical (STAA) and Organon (OGN)
STAAR Surgical Second Quarter 2024 Earnings: EPS: US$0.15 (Vs US$0.13 in 2Q 2023)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Cadrenal Therapeutics, Inc. (CVKD) and Allogene Therapeutics (ALLO)
A Glimpse Into The Expert Outlook On Staar Surgical Through 4 Analysts
Staar Surgical Hold Rating: Solid Performance Amid Global Economic Uncertainty and China Market Concerns